HUP0104716A3 - Triazineone compounds for treating diseases due to sarcosystis, neospora and toxoplasma and medicaments containing them - Google Patents
Triazineone compounds for treating diseases due to sarcosystis, neospora and toxoplasma and medicaments containing themInfo
- Publication number
- HUP0104716A3 HUP0104716A3 HU0104716A HUP0104716A HUP0104716A3 HU P0104716 A3 HUP0104716 A3 HU P0104716A3 HU 0104716 A HU0104716 A HU 0104716A HU P0104716 A HUP0104716 A HU P0104716A HU P0104716 A3 HUP0104716 A3 HU P0104716A3
- Authority
- HU
- Hungary
- Prior art keywords
- sarcosystis
- neospora
- toxoplasma
- treating diseases
- medicaments containing
- Prior art date
Links
- QMNWYGTWTXOQTP-UHFFFAOYSA-N 1h-triazin-6-one Chemical class O=C1C=CN=NN1 QMNWYGTWTXOQTP-UHFFFAOYSA-N 0.000 title 1
- 241001147660 Neospora Species 0.000 title 1
- 241000223996 Toxoplasma Species 0.000 title 1
- 201000010099 disease Diseases 0.000 title 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title 1
- 239000003814 drug Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/53—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/06—Antiabortive agents; Labour repressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Gynecology & Obstetrics (AREA)
- Pregnancy & Childbirth (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Tropical Medicine & Parasitology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US21871298A | 1998-12-22 | 1998-12-22 | |
PCT/US1999/030284 WO2000037084A1 (en) | 1998-12-22 | 1999-12-17 | Triazineone compounds for treating diseases due to sarcosystis, neospora and toxoplasma |
Publications (2)
Publication Number | Publication Date |
---|---|
HUP0104716A2 HUP0104716A2 (hu) | 2002-04-29 |
HUP0104716A3 true HUP0104716A3 (en) | 2003-10-28 |
Family
ID=22816194
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HU0104716A HUP0104716A3 (en) | 1998-12-22 | 1999-12-17 | Triazineone compounds for treating diseases due to sarcosystis, neospora and toxoplasma and medicaments containing them |
Country Status (12)
Country | Link |
---|---|
EP (1) | EP1140101A1 (hu) |
JP (1) | JP2002532552A (hu) |
KR (1) | KR20010080571A (hu) |
CN (1) | CN1331595A (hu) |
AU (1) | AU2198100A (hu) |
BR (1) | BR9916417A (hu) |
CA (1) | CA2356181A1 (hu) |
HK (1) | HK1043065A1 (hu) |
HU (1) | HUP0104716A3 (hu) |
NZ (1) | NZ512476A (hu) |
WO (1) | WO2000037084A1 (hu) |
ZA (1) | ZA200103919B (hu) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1119255A4 (en) | 1998-10-08 | 2009-04-15 | New Ace Res Company | NEW COMPOSITIONS AND METHOD FOR THE PREVENTION AND TREATMENT OF PROTOCOL DISEASES |
DE19958388A1 (de) * | 1999-12-03 | 2001-06-07 | Bayer Ag | Triazinonverbindungen zur Behandlung von durch den Befall mit parasitischen Protozoen bedingten Krankheiten |
DE10040174A1 (de) * | 2000-08-17 | 2002-02-28 | Bayer Ag | Verwendung von Triazintrion-Sulfonen zur Bekämpfung von Coccidiosen |
DE10040110A1 (de) * | 2000-08-17 | 2002-02-28 | Bayer Ag | Verwendung von Triazintrion-Sulfoxiden zur Bekämpfung von Coccidiosen |
DE102007025908A1 (de) * | 2007-06-01 | 2008-12-04 | Bayer Healthcare Ag | Formulierungen enthaltend Triazinone und Eisen |
DE102009012423A1 (de) * | 2009-03-10 | 2010-09-16 | Bayer Animal Health Gmbh | Zubereitung auf Ölbasis |
CN102973497A (zh) * | 2012-12-13 | 2013-03-20 | 江苏恒丰强生物技术有限公司 | 一种托曲珠利溶液及其制备方法 |
CN111819172B (zh) | 2018-02-26 | 2024-02-06 | 阿泽克制药公司 | 用于治疗与神经营养蛋白有关的疾病的三嗪衍生物 |
GB201810668D0 (en) | 2018-06-28 | 2018-08-15 | Stiftelsen Alzecure | New compounds |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BR9808114A (pt) * | 1997-03-31 | 2000-03-08 | David Granstrom | Formulação de ração para cavalos utilizável para tratar epm, processos para tratar pm em um cavalo que necessita deste tratamento, para prevenir infecção com s. neutrona em cavalos, e, para exterminar s. neurona em cavalos |
-
1999
- 1999-12-17 BR BR9916417-5A patent/BR9916417A/pt not_active IP Right Cessation
- 1999-12-17 EP EP99966449A patent/EP1140101A1/en not_active Withdrawn
- 1999-12-17 NZ NZ512476A patent/NZ512476A/en unknown
- 1999-12-17 HU HU0104716A patent/HUP0104716A3/hu unknown
- 1999-12-17 JP JP2000589195A patent/JP2002532552A/ja active Pending
- 1999-12-17 AU AU21981/00A patent/AU2198100A/en not_active Abandoned
- 1999-12-17 CA CA002356181A patent/CA2356181A1/en not_active Abandoned
- 1999-12-17 CN CN99815013A patent/CN1331595A/zh active Pending
- 1999-12-17 KR KR1020017006550A patent/KR20010080571A/ko not_active Application Discontinuation
- 1999-12-17 WO PCT/US1999/030284 patent/WO2000037084A1/en not_active Application Discontinuation
-
2001
- 2001-05-15 ZA ZA200103919A patent/ZA200103919B/en unknown
-
2002
- 2002-07-05 HK HK02105041.6A patent/HK1043065A1/zh unknown
Also Published As
Publication number | Publication date |
---|---|
KR20010080571A (ko) | 2001-08-22 |
CA2356181A1 (en) | 2000-06-29 |
WO2000037084A1 (en) | 2000-06-29 |
ZA200103919B (en) | 2002-05-15 |
BR9916417A (pt) | 2001-11-06 |
CN1331595A (zh) | 2002-01-16 |
NZ512476A (en) | 2003-08-29 |
HUP0104716A2 (hu) | 2002-04-29 |
EP1140101A1 (en) | 2001-10-10 |
JP2002532552A (ja) | 2002-10-02 |
HK1043065A1 (zh) | 2002-09-06 |
AU2198100A (en) | 2000-07-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB9801363D0 (en) | Novel dosage form | |
GB9818732D0 (en) | Collection of compounds | |
EP1073466A4 (en) | SOLUTION CONTAINING NICOTIN | |
PL345901A1 (en) | Benzothiepine-1,1-dioxide derivatives, method for producing them, medicaments containing these compounds and their use | |
GB9817118D0 (en) | Pharmaceutical compounds | |
GB9817623D0 (en) | Pharmaceutical compounds | |
HUP0104710A3 (en) | Triazineone compounds for treating diseases due to sarcosystis, neospora and toxoplasma and medicaments containing the same | |
GB9810886D0 (en) | Pharmaceutical compounds | |
HUP0104716A3 (en) | Triazineone compounds for treating diseases due to sarcosystis, neospora and toxoplasma and medicaments containing them | |
HUP0104595A3 (en) | Triazineone compounds for treating diseases due to sarcosystis, neospora and toxoplasma | |
HUP0103303A3 (en) | Imidazole compounds, process for producing them, their use and medicaments containing them | |
HUP0104620A3 (en) | 2-phenylpyran-4-one derivatives, process for their preparation and medicaments containing them | |
GB9823847D0 (en) | Pharmaceutical compounds | |
GB9808665D0 (en) | Therapeutic compounds | |
GB9823845D0 (en) | Pharmaceutical compounds | |
HUP0103569A2 (hu) | Új gyógyszerkészítmény és eljárás az előállítására | |
PL335668A1 (en) | Shield | |
GB9828620D0 (en) | Medicaments | |
GB9817197D0 (en) | Pharmaceutical compounds | |
GB9827865D0 (en) | Medicament | |
GB9808667D0 (en) | Therapeutic compounds | |
TW355367U (en) | Structure for safety syringe | |
GB9821694D0 (en) | Amphiphilogel dosage form | |
ZA989425B (en) | Dosage form | |
GB9826998D0 (en) | Medicaments |